BackMilestone Pharmaceuticals Overview

Milestone Pharmaceuticals Inventory

Milestone Pharmaceuticals's inventory is $4.7M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$4.72M

Peer trimmed avg / median

Loading

Milestone Pharmaceuticals Inventory History

Loading

Milestone Pharmaceuticals vs. peers: Inventory Comparison

Loading

Milestone Pharmaceuticals Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Milestone Pharmaceuticals (MIST) FAQ

Milestone Pharmaceuticals (MIST) currently reports a inventory of $4.7M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Milestone Pharmaceuticals's inventory history and peer comparisons.

Milestone Pharmaceuticals's inventory changed from $0 to $4.7M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Milestone Pharmaceuticals reported $4.7M in inventory as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $4.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Milestone Pharmaceuticals, and consider following MIST for alerts when major investors trade the stock.

Milestone Pharmaceuticals is classified in the Healthcare sector. On inventory, it currently shows $4.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MIST with unrelated industries.